Want to see HK:2190 full AI Analyst Report?
ETFs with Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190) Exposure
The following ETFs maintain exposure to Zylox-Tonbridge Medical Technology Co., Ltd. Class H (HK:2190). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
18 ETFs Hold Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in 2190 |
|---|---|---|---|---|---|---|
| IBRN | iShares Neuroscience and Healthcare ETF | $6.66M | 0.47% | 0.48% | $31.84K | <0.01% |
| ECNS | iShares MSCI China Small-Cap ETF | $56.30M | 0.59% | 0.28% | $156.26K | 0.02% |
| H41F | HSBC MSCI Emerging Markets Small Cap ESG UCITS ETF | $66.82M | 0.52% | 0.04% | $29.51K | <0.01% |
| IUS9 | iShares MSCI AC Far East ex-Japan SmallCap UCITS ETF USD | $70.06M | 0.82% | 0.03% | $23.76K | <0.01% |
| AVEE | Avantis Emerging Markets Small Cap Equity ETF | $140.69M | 0.42% | 0.03% | $46.68K | <0.01% |
| EEMS | iShares MSCI Emerging Markets Small Cap ETF | $360.61M | 0.72% | 0.03% | $107.73K | 0.01% |
| EMSM | SPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD | $599.03M | 0.55% | 0.03% | $171.46K | 0.02% |
| EWX | SPDR S&P Emerging Markets Small Cap ETF | $624.66M | 0.65% | 0.03% | $160.44K | 0.02% |
| DGS | WisdomTree Emerging Markets SmallCap Dividend Fund | $1.61B | 0.58% | 0.02% | $334.35K | 0.04% |
| AVEG | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | <0.01% | $24.95K | <0.01% |
| CAEM | Avantis CIBC Emerging Markets Equity ETF Trust Unit | $154.94M | ― | <0.01% | $6,854.87 | <0.01% |
| IEMG | iShares Core MSCI Emerging Markets ETF | $150.34B | 0.09% | <0.01% | $4.22M | 0.51% |
| SEDM | iShares MSCI EM IMI ESG Screened UCITS ETF | $1.26B | 0.18% | <0.01% | $170.23K | 0.02% |
| XEC | iShr Core EmrgMktIMI | $4.62B | 0.30% | <0.01% | $82.17K | <0.01% |
| XEC.U | iShares Core MSCI Emerging Markets IMI Index ETF Trust Units | $16.83M | 0.30% | <0.01% | $82.17K | <0.01% |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | <0.01% | $138.39K | 0.02% |
| AVEM | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | <0.01% | $316.91K | 0.04% |
| DFAE | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | <0.01% | $83.28K | 0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in 2190 |
|---|---|---|---|---|---|---|
| IBRN | 0.48% | iShares Neuroscience and Healthcare ETF | $6.66M | 0.47% | $31.84K | <0.01% |
| ECNS | 0.28% | iShares MSCI China Small-Cap ETF | $56.30M | 0.59% | $156.26K | 0.02% |
| H41F | 0.04% | HSBC MSCI Emerging Markets Small Cap ESG UCITS ETF | $66.82M | 0.52% | $29.51K | <0.01% |
| IUS9 | 0.03% | iShares MSCI AC Far East ex-Japan SmallCap UCITS ETF USD | $70.06M | 0.82% | $23.76K | <0.01% |
| AVEE | 0.03% | Avantis Emerging Markets Small Cap Equity ETF | $140.69M | 0.42% | $46.68K | <0.01% |
| EEMS | 0.03% | iShares MSCI Emerging Markets Small Cap ETF | $360.61M | 0.72% | $107.73K | 0.01% |
| EMSM | 0.03% | SPDR EM Sma Cap Accum.Shs Exchage Traded Fund USD | $599.03M | 0.55% | $171.46K | 0.02% |
| EWX | 0.03% | SPDR S&P Emerging Markets Small Cap ETF | $624.66M | 0.65% | $160.44K | 0.02% |
| DGS | 0.02% | WisdomTree Emerging Markets SmallCap Dividend Fund | $1.61B | 0.58% | $334.35K | 0.04% |
| AVEG | <0.01% | Avantis Emerging Markets Equity Ucits ETF AccumUSD | $312.59M | 0.38% | $24.95K | <0.01% |
| CAEM | <0.01% | Avantis CIBC Emerging Markets Equity ETF Trust Unit | $154.94M | ― | $6,854.87 | <0.01% |
| IEMG | <0.01% | iShares Core MSCI Emerging Markets ETF | $150.34B | 0.09% | $4.22M | 0.51% |
| SEDM | <0.01% | iShares MSCI EM IMI ESG Screened UCITS ETF | $1.26B | 0.18% | $170.23K | 0.02% |
| XEC | <0.01% | iShr Core EmrgMktIMI | $4.62B | 0.30% | $82.17K | <0.01% |
| XEC.U | <0.01% | iShares Core MSCI Emerging Markets IMI Index ETF Trust Units | $16.83M | 0.30% | $82.17K | <0.01% |
| DFEM | <0.01% | Dimensional Emerging Markets Core Equity 2 ETF | $9.08B | 0.39% | $138.39K | 0.02% |
| AVEM | <0.01% | Avantis Emerging Markets Equity ETF | $27.48B | 0.33% | $316.91K | 0.04% |
| DFAE | <0.01% | Dimensional Emerging Core Equity Market ETF | $9.42B | 0.29% | $83.28K | 0.01% |
Popular ETF Comparisons
2190 ETF Exposure FAQ
What ETFs hold Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (HK:2190) is currently held by 18 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to HK:2190 include WisdomTree (DGS), SPDR (GB:EMSM) and State Street (EWX).
Which ETF has the largest exposure to HK:2190?
The ETF with the largest exposure to HK:2190 is WisdomTree (DGS), with approximately HKD 334.35K in market value exposure.
How much HK:2190 stock is held by ETFs?
ETFs currently hold approximately HKD 1.09M worth of Zylox-Tonbridge Medical Technology Co., Ltd. Class H (HK:2190) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.